Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
This is a study to demonstrate the superiority of the immune response of adjuvanted influenza vaccine induced in an adult population.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
The subjects must be healthy adults 18-40 years or \>/= 50 years.
You may not be if
Subjects will be excluded if they take/have taken chronically high doses of immunosuppressants or other immune modifying drugs within six months before vaccination, or immunoglobulins or blood products within three months before vaccination, or any investigational product within 30 days before vaccination, or a licensed vaccine within 2 (inactivated) to 4 (live) weeks before vaccination, if women are pregnant or lactating, or if subjects have acute clinically significant disease or an immunosuppressive/deficient condition, or have contra-indications to influenza vaccination.
